Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

AstraZeneca scores in final lung disease drug trials

AstraZeneca scores in final lung disease drug trials AZ already sells a combination beta agonist/corticosteroid product for COPD called Symbicort (fotmoterol/budesonide), although this has now started to face generic competition in some markets.

GSK sees COPD future in triple therapy

GSK sees COPD future in triple therapy The latest phase III trial - called FULFIL - will compare the trio of fluticasone, umeclidinium and vilanterol to AstraZeneca's twice-daily therapy Symbicort (budesonide and formoterol) on lung function, exacerbation rates

AZ adds to respiratory portfolio with Actavis drugs

AZ adds to respiratory portfolio with Actavis drugs AZ's respiratory portfolio already includes drugs such as Symbicort and Pulmicort and the company is committed to making respiratory one of its three main areas of focus alongside diabetes and

AZ's new COPD therapy gets green light in Europe

AZ's new COPD therapy gets green light in Europe AZ already sells a combination beta agonist/corticosteroid product for COPD called Symbicort (fotmoterol/budesonide), although this has now started to face generic competition in some markets.

Nexium windfall lifts AZ in third quarter

Nexium windfall lifts AZ in third quarter There were also good performances for AZ's respiratory portfolio - headed by Symbicort (budesonide and formoterol) for asthma and chronic obstructive pulmonary disease (COPD) which grew 15% to $967m - as well

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics